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Magnetic nanoparticles (M:NPs) are unique agents for in vivo thermal therapies due to 
their multimodal capacity for efficient heat generation under optical and/or magnetic 
excitation. Nevertheless, their transfer from laboratory to the clinic is hampered by the 
absence of thermal feedback and by the influence that external conditions (e.g. 
agglomeration, matrix interactions) have on their heating efficiency. Overcoming these 
limitations requires, first, the implementation of strategies providing thermal sensing to 
M:NPs in order to obtain in situ thermal feedback during thermal therapies. At the same 
time, M:NPs should be modified so that their heating efficiency will be maintained 
independent of the environment and the added capability for thermometry. In this work, 
we present optomagnetic hybrid structures (OMHSs) that simultaneously satisfy these 
two conditions. Polymeric encapsulation of M:NPs with neodymium-doped nanoparticles 
(Nd:NPs) results in a hybrid structure capable of subtissue thermal feedback while 
making the heating efficiency of M:NPs independent from the medium. The potential 
application of the OMHSs herein developed for fully controlled thermal therapies is 
demonstrated by an ex vivo endoscope-assisted controlled intracoronary heating 
experiment. 
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1. Introduction 
Hyperthermia as a means to treat pathogens or diseases has been known to mankind over 
the ages.[1] Due to the systemic nature of classical, non selective, hyperthermia treatments 
mediated by ultrasound,[2] microwaves[3] or infrared radiation,[4] hyperthermia is not well 
represented in current medical applications. Conversely, local hyperthermia is increasing 
in relevance thanks to the progress of nanotechnology and material science. Different 
types of nanoparticles (NPs) can act as efficient and local nanoheaters (NHts) through 
remote-activation by e.g. infrared irradiation[5] and/or alternating magnetic fields (HAC),[6] 
which leads to therapeutic effects through the activation of protein- and DNA-
denaturation in the targeted cells or through direct thermal ablation of the cells.[7] The 
first works reporting the application of NHts in magnetic hyperthermia (MH) date back 
to the 50s,[6b] and more recently, numerous studies showing the success of proofs of 
concept and clinical trials have boosted the research interest into them. [6a, 6c, 8] Among 
these magnetic nanoparticles (M:NPs), iron oxide nanoparticles (IONPs) are the most 
widely employed.[9] Their success relies on the precise control of their magnetic 
properties, negligible toxicity and the wide variety of available surface modification 
methods for providing high colloidal stability in biological media and for anchoring 
biomolecules.[10] Over the last years M:NPs have also emerged as efficient light-to-heat 
converters, showing great potential for the development of new in vivo thermal therapies 
of malign tumors by using infrared irradiation as external stimulus.[11] Furthermore, in 
vivo experiments also demonstrated the synergetic benefits of performing simultaneous 
(optical plus magnetic) activation of M:NP-mediated heating.[5] The combination of both 
heating mechanisms makes M:NPs unique minimally-invasive thermal agents. 
Actually, the successful translation of M:NPs into the clinic is hampered by two inherent 
drawbacks. First, the significant reduction of the magnetic heating generated by M:NPs 
inside biological matrices, and second, the lack of thermal feedback. The first drawback 
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is related to the influence of biological matrices on the magnetic properties of M:NPs. 
Recent works show that they increase NP clustering inside cells or tissues, resulting in 
relevant modifications of their magnetic response (including magnetic heating, and 
imaging signals).[12] Indeed, it was found that magnetic dipolar interactions and 
nanoparticle immobilization are responsible (to different extents) for a reduction of the 
magnetic heating efficiency up to 90%. This makes it difficult to control the heat dose 
during an in vivo M:NP-based hyperthermia treatment. The second drawback stems from 
M:NPs currently not offering any intrinsic property that can provide real time thermal 
feedback during a thermal treatment. Most of the in vivo demonstrations of M:NPs-based 
thermal therapies aim for thermal control through temperature measurements with 
infrared thermal cameras. These often fail to give an accurate subcutaneous / intratissue 
thermal reading as they can only access surface (skin) temperature that could differ 
significantly, for example, from the actual intratumoral temperature.[8c, 13] As a 
consequence, inaccurate therapies and undesired and harmful side effects con occur. 
Overcoming these two limitations implies the development of a modification that would 
equip M:NPs with a contactless subcutaneous thermal feedback functionality while 
preserving their heating efficiency in biological tissues. 
Providing M:NPs with thermal control can be achieved through combination with 
luminescent nanothermometers (LNThs); nanoparticles whose luminescence is strongly 
temperature-dependent in the physiological range (20 - 60 ºC). A great variety of LNThs 
was successfully employed for temperature control in in vitro and in vivo thermal 
therapies.[14] Subcutaneous thermal feedback requires the use of LNThs working in the 
so-called biological windows (BWs). BWs are spectral ranges, covering from 700 up to 
1870 nm, in which tissues become partially transparent so that large optical penetration 
depths are achieved.[15] Furthermore, accurate and consistent luminescence thermometry 
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requires the use of LNThs capable of multiparametric temperature determination (i.e. 
showing different temperature dependent spectral parameters).[16] In this case the 
combination of luminescence thermometry and neural network recognition has made 
luminescence thermal sensing with thermal and time resolutions as good as 0.2 °C and 10 
ns possible.[17] Thermal control of M:NPs by luminescence thermometry has already been 
successfully demonstrated, combining M:NPs with rare earth compounds or organic dyes 
emitting in the visible domain,[18] limiting their employability for in vivo applications that 
demand high penetration into tissues. Furthermore, in previous cases temperature 
determination was based on a single parameter analysis, reducing the robustness of the 
thermal feedback. The combination of M:NPs and multiparameter infrared LNThs for 
subtissue accurate thermal sensing is therefore still a challenge that has not yet been 
accomplished. 
In order to satisfy these conditions (multiparametric thermal sensitivity in the infared 
BWs), neodymium-doped LaF3 nanoparticles (Nd:NPs) appear of special relevance due 
to their already demonstrated capability for providing real time and accurate thermal 
control during in vivo thermal therapies.[14e, 19] Furthermore, Nd:NPs were also recently 
demonstrated to be outstanding thermal controllers of NHts and a “green” hydrothermal 
microwave treatment (HTMW) technique demonstrated to significantly enhance their 
fluorescence brightness allowing their use as infrared contrast agents.[16, 20] Thus, the 
combination of both M:NPs and Nd:NPs into a single nanostructure would allow for 
accurate and real time thermal feedback in M:NP-based thermal therapies under optical 
and/or magnetic excitation. Such a desired structure is schematically drawn in Figure 1. 
Among the alternatives to combine M:NPs and Nd:NPs into a single nanostructure, 
encapsulation with the polymer poly(lactic-co-glycolic acid) (PLGA) emerges as 
especially relevant.[21] PLGA encapsulation would ensure good biocompatibility allowing 
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for the safe in vivo application of the hybrid structure.[21-22] Furthermore, polymeric 
encapsulation randomly immobilizes M:NPs, freezing the interparticle distance, i.e. the 
magnetic dipolar interactions,  which should preserve the magnetic heating efficiency. 
Although polymeric encapsulation of M:NPs with Nd:NPs could simultaneously solve 
the two limitations of M:NPs as thermal agents, it is still an unexplored solution. 
In this work we have designed and synthetized hybrid nanostructures containing 
simultaneously both M:NPs in the form of IONPs and Nd:NPs. Hybrid nanostructures 
were obtained by joint encapsulation of both M:NPs and Nd:NPs with the biocompatible 
polymer PLGA via a typical double emulsion method and decorated on the surface with 
a polyethylenglycol ligand in order to improve water dispersability.[21, 23] The developed 
optomagnetic hybrid nanostructures (OMHSs) combine the heating capabilities of the 
M:NPs with the multiparametric sensing ability of the Nd:NPs. A series of experiments 
were conducted to demonstrate the benefits of polymeric encapsulation not only in terms 
of thermal feedback but also in maintaining the heating efficiency of the M:NPs. Finally, 
the potential application of the OMHSs for in situ controlled thermal therapies is explored 
by the design and development of simple ex vivo experiments. 
 
2. Results and Discussion 
After the synthesis of the OMHSs was successfully conducted as described in the 
Experimental Section a detailed morphological analysis was performed. Figure 2(a) 
includes a TEM image of a single OMHS. In this image, the presence of individual 
nanoparticles within a polymeric capsule is evidenced. This polymeric capsule has a 
diameter of ≈ 300 nm on the TEM grid although the average hydrodynamic diameter (DH) 
of the OMHSs dispersed in water was 185 ± 76 nm (see Section 2 and Figure S1 in the 
Supporting Information). This is quite similar to the size of previously reported hybrid 
polymeric nanostructures.[22] Figure 2(a) reflects the nanoparticle encapsulation but it 
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does not clarify the content nor the joint encapsulation of Nd:NPs and M:NPs in the 
polymeric capsule. High-angle annular dark-field imaging (HAADF) compositional 
imaging experiments were performed to verify the capsule composition and the results 
are shown in Figures 2(b), (c), and (d). In particular, Figure 2(c) and 2(d) correspond to 
the HAADF images obtained in terms of the Lanthanum and Iron content. These two 
images denote the simultaneous presence of both LaF3:Nd and γ-Fe2O3 NPs within the 
polymeric capsule. Additionally, the average composition of the OMHSs was determined 
by inductively coupled plasma - optical emission spectrometry (ICP-OES) and 
thermogravimetric analysis (TGA) (for details see the Supporting Information and Figure 
S2) and resulted in 20 % iron oxide, 50 % LaF3 and 30 % organic material (PLGA and 
surface coatings). 
Further evidence of joint encapsulation is shown in Figure 3. Figure 3(a) depicts the 
optical image of the OMHSs’ dispersion (1 mg/mL) in phosphate-buffered saline (PBS). 
The dispersion appears homogeneous with a light brown color, attributed to the 
distribution of the polymeric capsules. Figure 3(b) shows the same colloidal dispersion 
when a magnet is placed in close proximity. The dispersion becomes transparent and it is 
evident that all the encapsulates have been attracted towards the magnet due to the 
magnetic force exerted over the encapsulated γ-Fe2O3 NPs. The good magnetic properties 
of the encapsulated IONPs are also reflected in the magnetization cycles of the OMHSs 
at room temperature (see Figure S3). Additional evidence of the joint encapsulation of 
M:NPs and Nd:NPs in the polymer is shown in the infrared fluorescence images of the 
cuvette in the absence and presence of the magnet (see Figures 3(c) and (d)). Optical 
excitation was performed by an 808 nm diode laser and the image was acquired by using 
an InGaAs infrared camera combined with a longpass filter so that the infrared 
fluorescence image is unequivocally correlated with the presence of OMHSs in the 
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suspension. Figure 3(c) shows the infrared fluorescence image of the suspension in 
absence of the magnet. This image suggests an homogeneous distribution of luminescent 
Nd:NPs. On the other hand, in presence of the magnet, luminescence is only detected in 
its proximities, denoting that all the Nd:NPs moved in unison with the M:NPs and no 
emission from “free” Nd:NPs was observed, i.e. all the Nd:NPs are within OMHSs. Thus, 
Figures 3(a)-(d) constitute a solid evidence of the simultaneous encapsulation of both 
Nd:NPs and M:NPs within the OMHSs. 
Figure 3(e) shows the optical extinction coefficient of a colloidal solution of OMHSs in 
PBS. For the sake of comparison, the absorption extinction spectrum of PBS is also 
included. The difference between the two extinction spectra included in Figure 3(e) 
evidences that the OMHSs present a non-vanishing extinction cross section in the 500-
1400 nm spectral range. Indeed, the extinction cross section of OMHSs increases 
noticeably at shorter wavelengths in very good accordance with the extinction spectra 
reported for a great variety of magnetic structures.[5, 11, 24] At this point it should be noted 
that the narrow absorption lines of Nd:NPs are not observed in the extinction spectrum of 
OMHSs, thus indicating that optical extinction is mainly given by the presence of M:NPs 
within the polymeric capsules. The absence of sharp bands in the extinction coefficient 
of OMHSs is an outstanding point since it suggests that the absorption coefficient and, 
hence, the optical-to-heat conversion efficiency will not be as dependent on the particular 
excitation wavelength as it happens with rare-earth-based or plasmonic NHts.[19a, 25] 
Figure 3(f) shows the room temperature emission spectrum as obtained when a dispersion 
of OMHSs was optically excited with an 808 nm diode laser. The emission spectrum is 
constituted by three emission bands centered at around 900, 1060 and 1340 nm that are 
unequivocally correlated to the 4F3/2 → 4I9/2, 4I11/2, and 4I13/2 transitions, respectively. 
There is no evidence of the presence of additional emission bands neither due to the 
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polymeric capsule nor to the magnetic nanoparticles. This fact reveals Nd:NPs as the 
unique fluorescent unit within the OMHSs. Furthermore, the shape of the emission bands 
generated by the Nd:NPs within the OMHSs is virtually the same as that of colloidal 
Nd:NPs.[26] This suggest that neither the encapsulation procedure nor the proximity of 
M:NPs have any relevant influence on the fluorescence properties of the Nd:NPs.  
Finally, in order to evaluate the influence of the encapsulation procedure on the magnetic 
heating efficiency of M:NPs, Figure 3(g) shows the values of the specific absorption rate 
(SAR) obtained for differently coated (oleic acid (OA) and dimercaptosuccinic acid 
(DMSA)) IONPs. Figure 3(g) also includes the SAR values obtained for OMHSs at two 
different aggregation levels denoted as OMHSs and OMHSs-BSA, with DH  values of 209 
nm and 503 nm but similar size distributions (poly dispersity index (PDI) of 0.26 and 
0.22, respectively). The modification of DH was achieved through addition of bovine 
serum albumin (BSA) as explained in detail in the Experimental Section. The observed 
SAR values were obtained with a field frequency and intensity of 100 kHz and 24 kA/m, 
respectively. As shown in the figure, the SAR values remain identical for OA and DMSA 
coated IONPs, but significantly drop (∼50%) when IONPs are integrated into OHMSs. 
This drop can be understood in terms of the interparticle interaction inside the OMHS 
encapsulate. [27] Such dipolar interacting phenomena are clearly observed when DMSA-
coated IONPs are intentionally aggregated (see Figure S4) and their hydrodynamic size 
is increased from 99 to 208 nm. Their SAR values decrease 35 % due to the increase of 
the intra-aggregate magnetic dipolar interactions. The SAR value is also 35% reduced 
when the viscosity is 100-fold increased, demonstrating that IONP immobilization 
decreases the heat losses. In this way, one can understand that the SAR value of OMHSs 
decreases more than 40% with respect to DMSA-coated IONPs, as a consequence of 
intra-aggregate dipolar interactions and particle immobilization inside the OMHS 
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capsule. However, no remarkable differences of SAR values are observed when the DH 
of OMHSs is intentionally increased from 208 to 503 nm, underlining the invariability of 
magnetic heating of OMHSs when aggregation is induced. This can be understood in 
terms of the preservation of the interparticle distance inside the OMHSs capsule, resulting 
in no significant effects when another capsule approaches. In summary, Figure 3 reveals 
the encapsulation with PLGA as an efficient technique to join M:NPs and Nd:NPs into a 
single nanostructure while preserving their desired optical and magnetic properties. 
Figure 4 summarizes the results obtained from the experiments conducted to evaluate the 
contactless thermal sensing capacity of OMHSs. Details about the experimental 
procedure used for thermal calibration can be found in the Experimental Section. Figure 
4(a) shows a detail of the 4F3/2→4I9/2 emission band of Nd3+ ions as obtained at two 
different temperatures. Relevant changes are observed. Firstly, there is a noticeable 
spectral change. The ratio R = I1 / I2 between the emitted intensities at 862.5 and 864 nm 
(denoted as I1 and I2, respectively) increases with temperature. This increment, shown in 
Figure 4(b), can be used for ratiometric thermal sensing. The temperature dependence of 
the ratiometric thermal sensitivity, SR that is defined as SR = R-1 · dR dT-1 is also shown 
in Figure 4(b). At 30 °C the ratiometric thermal sensitivity has been found to be close to 
0.4% °C-1, which is indeed comparable to that recently published for optimized LaF3:Nd 
NPs,[19c] although it is lower than the ratiometric thermal sensitivities reported for other 
luminescent nanoparticles.[28] Nevertheless, previous studies demonstrated that this 
thermal sensitivity is high enough to allow for accurate subtissue remote thermal 
measurements.[19b] In addition to their ratiometric thermal sensitivity, OMHSs possess an 
additional thermal reading possibility through the spectral shift of their emission line at 
around 864 nm. As can be observed in Figure 4(c) this emission line suffers a linear 
temperature induced redshift at a rate of 0.002 nm °C-1. This double thermal sensitivity is 
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an outstanding feature that converts the OMHSs into robust thermal sensors since it 
allows for a double-check of the thermal readout. Note that, as it is explained in the 
Experimental Section, the reduced spectral shift of the 864 nm line does not imply that 
thermal measurements based on this spectral shift require a high resolution spectrometer. 
Indeed, peak position is determined by fitting the emission spectra to three Gaussian 
peaks and it was found that the use of a spectrometer with a resolution of 0.2 nm is enough 
to determine temperature from the spectral shift at 864 nm. Regarding the physical 
mechanisms causing the temperature induced spectral changes, they have been explained 
in previous papers. Briefly, the temperature induced change in the ratio between emission 
lines can be correlated with a thermal re-distribution between the sub-stark levels of the 
4F3/2 and 4I9/2 electronic levels of the Neodymium ions in the LaF3 network. At the same 
time the red-shift of the emission line was unequivocally associated with thermally 
induced strains in the Nd3+ environment that occur as a result of electron-phonon 
interaction.[ ACS Nano, 2013, 7 (2), pp 1188–11999] 
Having successfully characterized the OMHSs, their applicability was to be demonstrated 
in ex vivo experiments. Figure 5 shows a schematic representation of the experimental 
set-up designed in this work to demonstrate the suitability of our OMHSs for subtissue 
heating under optical or magnetic activation with simultaneous contactless thermal 
feedback (more details about this set-up can be found in the Experimental Section). 
Briefly, powdered OMHSs are deposited inside a quartz tube placed in the coil gap, where 
a homogenous HAC (100 kHz and 0-32 kA m-1) is applied. The OMHSs are optically 
excited with an 808 nm diode laser coupled to a multicore fiber. The fluorescence 
generated by the OMHSs was collected by the same multicore fiber and was spectrally 
analyzed by a high resolution monochromator. The sample was irradiated with excitation 
light 5 min before spectrum acquisition in order to achieve the required dynamical 
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equilibrium temperature for thermal measurements. Details about thermal stabilization 
can be found in Supporting Information. This set-up allows us to place a tissue between 
the optical fiber and the OMHSs. Information about the thermal resolution achieved in 
this experimental configuration can be found in Supporting Information. 
Figure 6(a) shows the emission spectra generated by the powdered OMHSs in the 
absence of any applied magnetic field and tissue as obtained for two different 808 nm 
laser powers. As can be observed increasing the laser power from 10 mW up to 380 mW 
leads to a clear modification in the emission spectrum. The intensity ratio R is increased 
and the emission line at 864 nm is simultaneously redshifted, both indicating a local 
temperature increment inside the OMHSs. Similar results were obtained when a 
biological tissue (chicken breast, 3 mm thick) was placed between the end of the 
multicore-fiber and the powdered OMHSs. Figure 6(b) shows the OMHSs temperature 
increment as a function of the 808 nm laser power obtained in the absence and presence 
of the tissue. Figure 6(b) includes the temperature increments calculated from the analysis 
of the changes induced in the intensity ratio R (denoted as ΔTR) as well as those calculated 
from the spectral shift of the 864 nm emission line (denoted as ΔTλ). In the presence and 
in the absence of the tissue, both thermometry procedures lead to equal temperature 
increments, supporting the correctness of the measurements. At this point, it should be 
noted that the presence of the tissue reduces the magnitude of the laser-induced heating 
in the OMHSs. The rate at which temperature increases in respect to laser power was 
found to decrease from 400 down to 39 °C W-1 when the OMHSs were placed under the 
tissue. Such drastic reduction was, indeed, expected due to the extinction of the 808 nm 
laser beam when crossing the tissue. The extinction coefficient of breast tissue at 808 nm 
was estimated to be close to 8 cm-1. Applying the Beer-Lambert law and taking into 
account the tissue thickness used in our experiments (3 mm) the 808 nm laser intensity 
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reaching the OMHSs beneath the tissue is estimated to be only 10% of the optical power 
delivered by the diode laser.[29] This is in good agreement with the reduction 
experimentally observed in the heating rates which is close to one order of magnitude. 
Similar measurements were also performed by placing a 2 mm thick skin tissue (from 
chicken) as well as from a 3 mm thick sample of bold (obtained from a sacrificed mouse). 
We found that the optical power, after passing the skin tissue and blood sample, was 
reduced down to 15 % and 4 % of its incident value, respectively. This can be compared 
with the expected reduction that can be calculated by the Beer-Lambert law and the 
effective attenuation coefficients of skin and blood at 808 nm reported in the literature (8 
and 17 cm-1, respectively).[doi:10.1038/nnano.2009.326 and 
https://doi.org/10.1111/1523-1747.ep12479191] Using these values Beer-Lambert law 
predicts a transmitted laser power  that is 20 and 3% of the incident laser power for skin 
and blood, respectively.  These are also in reasonable good agreement with the 
experimental data.  
Figure 6(c) shows the emission temperature generated by the OMHSs for a fixed 808 nm 
excitation power (2.5 W) as obtained in absence (blue line) of any magnetic field and 
when a HAC (100 kHz and 32 kA m-1) was applied (red line). These thermal sensing 
experiments were performed in the presence and absence of the tissue. A detailed 
inspection of both spectra reveals that when applying the alternating magnetic field, the 
intensity ratio R slightly increases and this is accompanied by a small red-shift of the 
emission line at around 864 nm. These two facts reveal the magnetic field-induced heating 
of OMHSs. An analysis of both the intensity ratio and spectral shift allowed us to 
determine the OMHSs temperature increment as a function of the intensity of the 
alternating applied magnetic field. The results obtained in the presence and the absence 
of the tissue are included in Figure 6(d). Again both ratiometric and spectral analysis of 
  
14 
 
the emission spectrum leads to virtually the same thermal reading. Temperature increment 
induced in the OMHSs were found to increase linearly with the intensity of the magnetic 
field as it was, indeed, expected and observed in previous works.[18b-c] For the maximum 
field intensity applied by our generator (32 kA m-1) the temperature increment induced 
within the OMHSs was found to be close to 10±1 °C. In order to check for the correctness 
of this value we recorded the temperature increment by using an infrared thermal camera. 
With this camera, due to its reduced spatial resolution, the temperature increment 
obtained corresponds to the average temperature increment in the whole sample of 
OMHSs. On the other hand, the temperature increment obtained by luminescence 
nanothermometry corresponds to the average temperature within the polymeric 
encapsulate (the Nd:NPs nanothermometers are within the OMHSs). Figure 6(e) shows 
the infrared thermal image of the OMHSs in absence of any applied magnetic field. As 
expected, no temperature contrast is observed and the OMHSs are at the same temperature 
as the thermostatic bath in which the magnetic coils are immersed. Figure 6(f) shows the 
thermal image when an alternating magnetic field of 32 kA m-1 was applied. In this case, 
the temperature of the OMHSs is significantly different from that of the thermostatic bath. 
Thermal images revealed a temperature increment of 11 °C that is virtually the same as 
that determined by luminescence nanothermometry. This fact indicates that, in this 
particular case, there is no significant difference between the temperature increments at 
the nanoscale, i.e. induced inside the encapsulates, and the macroscopic average 
temperature increments induced over a large sample. This in turn, suggest the presence 
of an efficient thermal diffusion within the polymeric capsule and between adjacent 
encapsulates. At this point these results can be compared to those obtained by R. Piñol et 
al. who found small differences between the nanoscale and bulk temperature increments 
caused by a colloidal solution of magnetic nanoparticles.[18a] This discrepancy can be 
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understood by recalling that in our case we are dealing with a solid sample of OMHSs so 
that thermal diffusion is expected to be larger than in an aqueous solution due to the 
presence of solid-liquid interfaces that could induce relevant thermal impedances. In any 
case, the good agreement between the thermal reading provided by luminescent 
nanothermometers and infrared thermal camera reveals the robustness of the structure 
here proposed for obtaining accurate thermal monitoring of magnetic nanoparticles. 
Figure 6(d) also reveals that the temperature increment induced in the OMHSs by the 
alternating magnetic field is not affected by the presence of the tissue. This varies from 
the observation for laser induced heating, and was expected due to the superior 
penetration of magnetic fields into tissues when compared to 808 nm laser radiation. 
When measuring the subtissue magnetic field induced heating of our OMHSs, the 
attenuation of 808 nm laser radiation only affects the signal to noise ratio of the measured 
spectrum (and hence the uncertainty of the thermal reading) but not the magnitude of 
heating as, in this case, it is given by the intensity of magnetic field that is not affected by 
the presence of the tissue. From data included in Figure 6(d) we can estimate a magnetic 
field induced heating rate in our OMHSs close to 0.31 °C m kA-1. This can now be 
compared to the magnetic-induced heating rates reported for single M:NPs. A. Riedinger 
and co-workers found that the heating rate, for M:NPs in an aqueous solution, is strongly 
dependent on the distance at which it is measured in respect to the M:NP. It was as large 
as 5 °C m kA-1 (with a frequency of 334 kHz) at the surface of the M:NP decreasing down 
to 0.63 °C m kA-1 for distances of 2 nm from the M:NP.[18c] Therefore, the heating rate of 
our OMHSs is comparable to the heating rate found in the past for single M: NPs but at 
moderate field conditions (100 kHz and 32 kA m-1, instead of 334.5 kHz and 8-16 kA m-
1). 
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At this point we should note that thermal measurements were obtained after analyzing the 
luminescence generated by OMHSs after passing through the tissue and being partially 
scattered by it. At this point we state that scattering would be, indeed, a problem if thermal 
reading would be achieved through a single intensity analysis. But in our case we are 
dealing with a ratiometric analysis in which temperature is determined from the intensity 
ratio between two peaks that are very close in wavelength. Thus, scattering would affect 
both peaks equally and the ratio between them would only carry information about 
temperature. This also applies for the thermal reading based on the determination of peak 
wavelength. Note that spectral displacements are very reduced so we can consider that 
scattering affects all of them equally. Thus, the presence of the tissue induced scattering 
can affect the level of detected signal but not the thermal information extracted from it. 
In order to illustrate the potential of our OMHSs for fully controlled photothermal 
therapies, we performed an additional ex vivo experiment. A powder sample of OMHSs 
(2 mg) was introduced by a surgical incision into a lamb heart (see arrow in Figure 7(a)). 
Optical excitation of the OMHSs was performed by introducing a multicore fiber into the 
heart through the pulmonary vein (also indicated in Figure 7(a)). The multicore optical 
fiber was then positioned to maximize the collected fluorescence generated by the 
OMHSs. Once maximized, the emission spectrum was recorded for different 808 nm laser 
powers in order to measure the laser induced heating in the coronary wall. Figure 7(b) 
shows the emission spectra obtained for different laser powers ranging from 10 up to 37 
mW. The simultaneous increment in the intensity ratio R and the redshift of the 864 nm 
emission line evidences intracoronary heating due to the presence of OMHSs. The 
intracoronary temperature increment as a function of the 808 nm laser power, as 
calculated by using the calibration curves of Figures 4(b) and 4(c), is shown in Figure 
7(c). Once more, both thermal reading approaches lead to similar temperature increments 
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that in turn increase linearly with the 808 nm laser power. Note that the laser induced 
temperature increment obtained is as large as 50 °C for a moderate laser power of 35 mW. 
This temperature increment is large enough to induced both hyperthermia and tissue 
ablation.[30] In addition, the required laser power is moderate, allowing the use of a cheap 
combination of low power laser diodes and conventional optical fibers. Thus, results 
included in Figure 7 reveal the great potential of OMHSs as self-monitored thermal 
agents in heart therapies where, for instance, real time temperature monitoring would 
allow accurate control during intracoronary ablation processes that are used for the 
treatment of cardiac arrhythmias. At this point it should be noted that the temperature 
uncertainty in the ex vivo experiments has been estimated to be 5 °C (mainly due to the 
reduced signal to noise ratio).[19c] Such thermal accuracy is sufficient when dealing with 
thermal ablation of tissues (temperature increments of tens of degrees) but it is insufficient 
to provide thermal control during hyperthermia therapies in which temperature 
increments do not exceed 10 °C. Further improvement in thermal accuracy would be 
possible by improving the signal-to-noise ratio of the detection system as well as by 
applying neural network recognition procedures. 
 
3. Conclusion 
In summary, we demonstrated how polymeric encapsulation of magnetic nanoparticles 
with infrared emitting nanothermometers results in a hybrid nanostructure allowing in 
situ controlled hyperthermia treatment. The synthesized OMHSs keep the properties of 
both magnetic and luminescent nanoparticles, thereby providing an accurate thermal 
feedback that results in subtissue thermal control over IONP-mediated heating triggered 
by either magnetic and/or optical excitation. The encapsulation with PLGA was also 
found to preserve the magnetic heating efficiency against OMHS agglomeration. 
Therefore, the OMHSs here developed constitute a robust multifunctional platform 
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capable of fully controlled subcutaneous heating by using either optical or magnetic 
stimulation. The real potential of our OMHSs was demonstrated by an ex vivo 
intracoronary heating experiment in which subtissue remote heating with contactless 
thermal feedback was successfully achieved.  
Furthermore, the herein described OMHSs could constitute a reference material towards 
the design of controlled thermal therapies with reduced side effects and superior 
efficiency in respect to those based on single magnetic nanoparticles. The synergy 
between optical and magnetic induced heating in magnetic nanoparticles together with 
the possibility of real time thermal control over them will bring their therapeutic 
applications closer to the clinic. 
 
4. Experimental Section 
Chemicals and solvents were purchased from Sigma Aldrich, Alfa Aesar, Fisher, Acros 
Organics and if not stated otherwise in the procedure employed as purchased. Rare earths 
compounds and ammonium fluoride were obtained from Sigma Aldrich in the following 
purities: Nd(NO3)3·5 H2O (99.999% purity), La(NO3)3·6 H2O (99.999%), and NH4F 
(>98%).  
Synthesis of Nd-doped lanthanum trifluoride nanoparticles: For the synthesis of LaF3 
nanoparticles doped with 3% Nd3+ ions, La(NO3)3·6 H2O (0.485 mmol) and Nd(NO3)3·5 
H2O (0.015 mmol) were dissolved in deionized water (15 mL). The solution of rare-earth 
salts was added dropwise to the NH4F solution (5 mmol) in deionized water (25 mL) 
under vigorous stirring. To improve the dispersibility of the obtained nanoparticles, 1 g 
of biocompatible surfactant polyvinylpyrrolidone (Aldrich, average Mw ~55000) was 
added to the solutions. The surfactant was added to the rare-earth nitrates solutions before 
precipitation. The freshly precipitated gel was diluted with deionized water (10 mL) and 
left stirring for 15 minutes.The solution was transferred into a 100 ml Teflon autoclave 
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and placed under microwave irradiation for 2 hours at 200 °C using a Speedwave Four 
(Berghof GmbH, Germany) laboratory device (2.45 GHz, 1kW maximum output power). 
The resulting solution was cooled, centrifuged using a Thermo Scientific Heraeus 
Multifuge X1 device and washed several times with deionized water. The resulting 
powder was redispersed in deionized water. The morphology of the particles was 
determined by TEM (see Supporting Information Section 5 and Figure S5) and 
characterized by powder X-ray diffraction (Supporting Information Section 7 and Figure 
S8). 
Synthesis of magnetic nanoparticles: The reaction was carried out by thermal 
decomposition of Fe(acac)3 (3.53 g, 10 mmol), 1,2-dodecanediol (2.03 g, 10 mmol) and 
oleic acid (8.47 g, 30 mmol) in 1-octadecene (100 ml), under mechanical stirring.[31] The 
mixture was first heated to 200 °C and kept at that temperature during 2 h and, then, 
heated again until reflux for 30 minutes. The mixture was washed with ethanol, 
centrifuging and with the help of a permanent magnet. Finally, ethanol was removed and 
the resulting black residue of hydrophobic nanoparticles of magnetite was redispersed in 
hexane for storing. The mean size of the nanoparticles (determined by TEM, see Figure 
S6) was 21 ± 5 nm. Powder X-ray diffraction (Supporting Information Section 7 and 
Figure S9) confirmed the Fe3O4 structure. The iron concentration of the dispersion was 
measured by Inductively Coupled Plasma Optical Emission Spectrometry (ICP-OES). 
The aqueous M:NPs used for the encapsulation in this work were prepared by a surface 
modification procedure with DMSA, as previously described.[32] 
Polymeric encapsulation: The OMHS nanocapsules were synthesized via a double-
emulsion technique as described previously.[22] PLGA (50:50, MW 19000, 6 mg) was 
dissolved in dicloromethane (DCM,4 mL) and an aqueous dispersion of 
superparamagnetic iron oxide nanoparticles (M:NPs, 1 mL, 1 mg/mL) as well as an 
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aqueous dispersion of LaF3:Nd(3%) (Nd:NPs 1 mL, 40 mg/mL) were added dropwise 
while sonicating the mixture. The resulting water-in-oil emulsion was added to a solution 
of polyvinyl alcohol (PVA, 88% hydrolyzed, ≈MW 20–30 000, 200 mg) and DSPE-PEG-
folate (0.3 mg) in PBS (8 mL) and sonicated with a tip-sonicator with pulses of up to 20 
W for 5 min resulting in a water in-oil-in-water emulsion. In order to induce the hardening 
and facilitate the precipitation of the encapsulates the dispersion was combined with a 
solution of PVA (3.6 mg) in PBS (24 mL) and stirred overnight to achieve evaporation 
of the DCM. The resulting dispersion was centrifuged (Hermle Z206A, Rotor 55, Hermle 
Labortechnik GmbH) for 30 min at 6000 rpm and the OMHS were three times washed 
with H2O and centrifuged for 30 min at 6000 rpm. Afterward the encapsulates were 
recovered and lyophilized.  
Determination of the specific absorption rate: The characterization of the specific 
absorption rate (SAR) on the studied IONPs was determined from magnetic 
measurements of the AC hysteresis loops under given HAC (100 kHz and 24 kA m-1). The 
AC magnetomer employed is a custom-built inductive magnetometer set up developed 
by the Advanced Instrumentation Unit (iMdea Nanociencia) similar to the one described 
by Connord, et al.[33] The system quantifies the inductive magnetic signal of IONP 
dispersions, which is calibrated by comparing magnetization values at given field 
intensity obtained under AC and quasi-static conditions. Hysteresis loops were 
determined by averaging ten repetitions. By considering the expression SAR = A×f, 
where A is the area of the hysteresis loop under alternating magnetic fields, and f is the 
magnetic field frequency,[34] an average value of SAR and standard deviation were 
determined. 
Variation of the hydrodynamic radius during SAR measurements: For the reduction of 
the DH value of the OMHSs, a Bovine Serum Albumin dispersion (5 g/L) was added to 
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the aqueous nanoparticle dispersion to reach the final BSA concentration (0.35 g/L) and 
iron content (0.5 g/L). The dispersion was sonicated for 5 minutes resulting in a Z-average 
value of 209 nm (PDI=0.26). 
In order to increase the DH of the DMSA coated IONP, Fetal Bovine Serum (FBS) was 
added to the dispersion reaching a final fraction of 7 % (VFBS/Vwater) and an iron content 
of 0.5 g/L.[35] Immediately afterwards, the Z-average value was 231 nm (PDI=0.31). 
Spectroscopic characterization: For spectroscopic characterization a fiber coupled 808 
nm laser diode from LIMO was used as an excitation source. The laser fiber was coupled 
to fiber-based reflection probe (Ocean Optics QR600-7-VIS-NIR). It consists in a fiber 
bundle of a total of 7 fibers (600 µm diameter). The central fiber is coupled to the 808 nm 
laser source used for optical excitation. The 6 surrounding fibers are used to collect the 
luminescence of the sample. The collected luminescence was spectrally analyzed by 
coupling the exit branch of the bundle to an imaging spectrometer (Horiba iHR320). The 
luminescence, after dispersion by the grating, was recorded by a CCD array (Horiba 
Synapse). The spectral resolution of the system is 0.2 nm. Determination of the peak 
position was performed by fitting the emission spectra to a multiple Gaussian. The power 
of the 808 nm laser was adjusted by varying the diode current. The ferrule containing 
both illumination and collecting fibers was made of a ceramic material in order to avoid 
undesirable heating during magnetic experiments.  
For thermal calibration of our OMHSs, these were placed on a temperature controlled 
stage (Linkam 1200) that allowed to vary the sample temperature from -25 up to 120 °C 
with a 0.1 °C thermal resolution. 
For the acquisition of the fluorescence images included in Figure 3 the colloidal 
suspension of OMHSs was illuminated by an uncollimated 808 nm fiber coupled diode. 
Fluorescence image was acquired by a Peltier cooled InGaAs camera (XEVA 1.7 from 
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Xenics). A 850 nm longpass filter was used to block the 808 nm laser background. The 
room temperature extinction spectrum of the colloidal dispersions were measured with a 
double beam absorption spectrometer (Perkin Elmer Lambda1050). 
AC magnetic field generator: A custom-made and designed set-up was employed for 
generating the HAC enabling the measurement of the temperature raise of the OMHSs. 
The field conditions available were field frequencies up to 300 kHz and field intensities 
up to 32 kA/m. The HAC generator is based on a custom made and -designed liquid-cooled 
ferrite core, coiled with Litz wires, which is part of a LCR resonant circuit. The powder 
sample (1.2 mg) was placed in a quartz tube that was introduced into the coil. 
 
Supporting Information 
Additional experimental details and information on the characterization of the OMHS 
(TEM, size, compositional analysis, heating efficiency) can be found in the Supporting 
Information available from the Wiley Online Library or from the author. 
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Figure 1. Schematic drawing of the here designed hybrid nanostructure formed by 
Nd:NPs and M:NPs encapsulated in poly(lactic-co-glycolic acid) (PLGA) for thermal 
monitoring of laser and magnetic induced heat generation. 
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Figure 2. (a) TEM image of a OMHS nanostructure showing the polymer and the 
encapsulated nanoparties within it. (b) HAADF image of a single hybrid nanostructure. 
(c) and (d) correspond to the compositional images of the structure included in (b) as 
obtained in terms of the lanthanum and iron content, respectively. 
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Figure 3. (a) and (b) correspond to optical pictures of a PBS solution OMHS in absence 
and presence of a magnet, respectively. Note how the dispersion becomes more 
transparent due to the motion of OMHSs towards the magnet. (c) and (d) correspond to 
the infrared florescence images of the same solution also in absence and presence of a 
magnet, respectively. The solidary motion of luminescent and magnetic nanoparticles is 
evidenced. (e) Extinction spectrum of the colloidal solution of OMHSs. The extinction 
spectrum of PBS is also included for comparison. (f) Room temperature emission 
spectrum generated by OMHSs under 808 nm laser excitation. The three characteristic 
bands of neodymium ions are clearly observed. (g) Comparison of SAR values obtained 
for OA- or DMSA-coated IONPs (labeled as IONPs-OA and IONPs-DMSA, 
respectively). The SAR values obtained for OMHSs and OMHSs which were 
aggregated with bovine serum albumin (labeled as OMHSs-BSA) are also included. 
Each sample was dispersed in liquid media at equal concentrations in iron applying HAC 
(100 kHz and 24 kA m-1). 
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Figure 4. (a) Emission spectra of OMHSs in the 850-870 nm range as obtained for 
different temperatures (from 30 up to 60 °C). The intensities used for ratiometric 
thermal measurements are indicated. The peak used for spectral-shift thermal reading 
measurements is also included. (b) Temperature dependence of the intensity ratio R = 
I1/I2. The temperature dependence of the ratiometric thermal sensitivity, SR, is also 
included. Dots are experimental data and dashed lines are guides for the eyes. (c) 
Temperature dependence of the spectral shift induced in λpeak. Dots are experimental 
data and dashed line is the best linear fit. 
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Figure 5. Schematic representation of the experimental set-up designed to demonstrate 
the ability of OMHSs to provide subtissue thermal sensing during hyperthermia induced 
by optical or magnetic stimuli. 
  
  
33 
 
Dewar
Dewar
 
Figure 6. (a) Emission spectra generated by the OMHSs as obtained for two different 
laser powers: 10 (blue line) and 380 (red line) mW. Spectra were obtained in the 
absence of any tissue between the excitation/collection fiber and the solid OMHSs. (b) 
Temperature increment induced in the optically excited OMHSs as a function of the 
laser power as obtained through the ratiometric (∆TR) and spectral (∆Tλ) shift 
calibration. Results obtained in the presence and absence of tissue are included (circles 
and squares, respectively). (c) Emission spectra generated by the OMHSs as obtained in 
the absence (blue line) and presence (red line) of an alternating magnetic field (100 kHz 
and 32 kA m-1). (d) Temperature increment induced in the OMHSs as a function of the 
applied magnetic field in the presence and absence of tissue. Data obtained by using the 
ratiometric and spectral shift calibrations are included. (e) Thermal image of the quartz 
tube containing the OMHSs in absence of HAC. (f) Thermal image of the tube 
containing the OMHSs in the presence of HAC (100 kHz and 32 kA m-1). 
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Figure 7. (a) Optical image of the lamb´s heart used for the ex vivo experiments. The 
location of the optical fiber as well as the subtissue injected OMHSs are indicated. (b) 
Emission spectra obtained for different laser powers. (c) Temperature increment 
induced in the subtissue allocated OMHSs as a function of the laser power. Results 
obtained by using the ratiometric and spectral shift calibration are included. Dots are 
experimental data and the dashed line is a guide for the eyes. 
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The combination of magnetic nanoparticles and luminescent nanothermometers 
through encapsulation with a polymer into optomagnetic hybrid structures 
achieves in situ control of thermal therapies inside biological tissues. The magnetic 
and luminescent properties of the constituting nanoparticles are maintained and the 
robustness of the thermal feedback during photothermal and/or magnetic heating is 
demonstrated. 
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Section S1. Dynamic Light Scattering Studies 
 
DLS measurements were performed in a Zetasizer Nano ZS instrument (Malvern) in a 
standard 1 cm quartz cuvette on 0.1 mg/ml dispersion of the optomagnetic hybrid 
structures (OMHS) in water. The energy source was a laser emitting red light, and the 
angle between the sample and detector is 173°C. 
 
Figure S1. DLS revealed an average hydrodynamic radius of 185 ± 75 nm. 
 
  
  
38 
 
Section S2. Compositional analysis 
 
The Fe and La content of the OMHSs was measured by inductively coupled plasma-
optical emission spectrometry (ICP-OES, PerkinElmer Optima 2100 DV ICP) after acidic 
hydrolysis in aqua regia and dilution in doubly distilled water.  
The percent weight of the organic part of the encapsulates (PLGA + coatings) was 
obtained by thermogravimetric/differential thermal analysis (TGA/DTA) performed on a 
TA Instruments TGA 500 apparatus, applying a heating rate of 10 °C/min from room 
temperature to 1000 °C under air. Prior to the analysis, OMHSs were lyophilized to obtain 
the corresponding powder. 
 
Figure S2. TGA analysis of the OMHS. It reveals that 31 % of the material are organic 
stemming from the encapsulation with the polymer. This result is in good agreement with 
an ICP-MS performed on the nanostructures revealing 20 % iron oxide (19.95 % Fe2O3) 
and 50 % LaF3 (50.85 % ). 
 
  
  
39 
 
Section S3. DC Magnetic characterization. 
 
The magnetic characterization was carried out in a vibrating sample magnetometer at 
room temperature (Lakeshore, Oxford Instrument) by first saturating the sample in a field 
of 2 T. Saturation magnetization (MS, expressed in emu per g of magnetite, Fe3O4) was 
evaluated by extrapolating the experimental results obtained in the high field range, where 
the magnetization linearly increases with 1/H. 
 
Figure S3. Maghemite mass-normalized magnetization cycles of the OMHSs at room 
temperature. . 
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Section S4. Influence of aggregation, viscosity and encapsulation on 
SAR values  
 
 
Figure S4. Representation of the aggregation effect on SAR values of DMSA coated 
IONPs at different hydrodynamic sizes and viscosity values and in OHMSs dispersed in 
aqueous media under similar field conditions (100 kHz and 24 kA/m) and iron content 
(0.5 gFe/L)  
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Section S5. HRTEM images of LaF3:Nd nanoparticles and HAADF. 
 
HR TEM analysis of LaF3:Nd3+ nanoparticles synthesized via the microwave-
hydrothermal treatment of a freshly precipitated gel was performed using a FEI Titan 
Themis 200 microscope working at 80 kV, equipped with a high-angle annular dark field 
detector for 200 to 300 kV and the EDX signal was collected with a SuperX SDD 
(Bruker). The sample was prepared by dropping the colloidal solution of LaF3:Nd3+ 
nanoparticles in water onto a formvar coated copper grid (3 mm in diameter) followed by 
the evaporation of the solvent. From the obtained images (Figure S5) one can see, that 
the synthesized sample consists of well defined disaggregated hexagonal-shaped 
nanoparticles with a diameter of around 15-20 nm. Nanoparticles are very well 
crystallized; there is no sign of an outer amorphous layer, which frequently can be 
observed on nanoparticles synthesized via “wet” chemical routes like co-precipitation 
method at elevated temperature. The same instrument was also employed for HAADF 
measurements of OMHSs in order to obtain the HAADF images shown in Figure 2 of 
the article. 
 
  
Figure S5. HR TEM images of LaF3:Nd3+ nanoparticles. The nanoparticles are very 
well crystallized with no sign of an outer amorphous layer. 
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Section S6.- TEM of OMHS and M:NPs 
 
The TEM image of the OHMS in Figure 2 of the paper was obtained with a JEOL JEM 
1010 microscope operating at 100 kV. The sample was prepared by placing one drop of 
a dilute suspension in water onto a carbon coated copper grid and leaving it to dry at room 
temperature. The same instrument and method were used for the TEM image of the 
IONPs. 
 
 
Figure S6. A representative image of the employed IONPs. 
 
 
 
